| Dr Michelle A Klaumann, MD | |
|
2000 Highway 95 Ste 200, Bullhead City, AZ 86442-6057 | |
| (928) 758-1175 | |
| (928) 758-5191 |
| Full Name | Dr Michelle A Klaumann |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2000 Highway 95 Ste 200, Bullhead City, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508833187 | NPI | - | NPPES |
| 100149910D | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 04-22351 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle A Klaumann, MD 6 Executive Park Dr Ne, Suite10, Atlanta, GA 30329-2221 Ph: (404) 321-9900 | Dr Michelle A Klaumann, MD 2000 Highway 95 Ste 200, Bullhead City, AZ 86442-6057 Ph: (928) 758-1175 |
News Archive
Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Researchers at the MRC Lifecourse Epidemiology Unit, University of Southampton, have demonstrated that the degree to which a gene related to vitamin D action is switched on or off, when measured at birth, predicts bone density of the child at four years of age.
Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.
A growth factor used in clinical experiments to rescue dying brain cells in Parkinson patients may cause unwanted weight loss if delivered to specific areas of the brain, according to University of Florida researchers in the March online edition of Molecular Therapy.
More than 100,000 Geisinger Health System patients will have access to their doctors' notes for the first time through the secure MyGeisinger online patient portal when Geisinger expands OpenNotes in May due to the initiative's overwhelming success.
› Verified 1 days ago
Dr. Robert L Lock, Ii, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Highway 95, Suite 200, Bullhead City, AZ 86442 Phone: 928-758-1175 Fax: 928-758-5191 | |
Dr. Blake A Stamper, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2000 Highway 95, Suite 200, Bullhead City, AZ 86442 Phone: 928-758-1175 Fax: 928-758-5191 | |
Nathan Chad Weaver, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Ste 1, Bullhead City, AZ 86442 Phone: 928-444-1491 | |
Dr. Michael H Wright, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Ste C2, Bullhead City, AZ 86442 Phone: 928-444-1491 Fax: 928-444-1330 | |
James R Ingram, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Ste C1, Bullhead City, AZ 86442 Phone: 928-444-1491 Fax: 928-444-1330 |